Navigation Links
American Scientific Resources Retains National PR/IR Firm
Date:7/5/2011

WESTON, Fla., July 5, 2011 /PRNewswire/ -- American Scientific Resources, Inc. ("American Scientific Resources") (OTCQB: ASFX) today announced it has retained Martin E. Janis & Company, Inc., the 61-year old Chicago-based public relations/investor relations firm, to carry out a fully-integrated marketing and communications program for the company and its products.

(Logo: http://photos.prnewswire.com/prnh/20110124/NY34439LOGO)

The firm will be responsible for working with American Scientific Resources to help bring attention to the Company's product lines and will also work directly with company management to introduce the American Scientific Resources, Inc. to potential investors throughout North America.

Martin E. Janis & Company, Inc., founded in 1950, is a full service firm providing its services to public as well as private corporations, trade associations, and government and political entities and individuals.  The company has a particular niche in working with small, undiscovered companies that have unique products and services and the potential to grow into large well-known companies.

About American Scientific Resources, Inc.

American Scientific Resources, Inc. is a purpose-driven consumer product manufacturer specializing in the clinical, home healthcare, infant and juvenile products industries.  The Company sources and designs innovative health and safety products, developing advanced technology and intellectual property.  The Company's products, which include infrared thermometers and safe disposal systems for home use of sharps and needles associated with certain health care issues, are distributed through established relationships in-house and through an ever growing network of leading global healthcare distributors and retailers.  Brands under the American Scientific Resources umbrella include Kidz-Med, Disintegrator Plus and VeraTemp.

For more information, visit the corporate website at www.americansci.com, www.kidzmed.com and www.disintegratorplus.com.

Forward Looking Statements

The information contained herein includes forward-looking statements.  These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.  You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements.  Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity.  We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.  The safe harbor for forward looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

Beverly Jedynak
President
Martin E. Janis & Company, Inc.
312-943-1123
bjedynak@janispr.com

Investor contact:
Investor Relations
American Scientific Resources
IR@americansci.com
561-948-4863


'/>"/>
SOURCE American Scientific Resources, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese™
2. American Pain Foundation Launches New Educational Campaign, "Explain Your Pain," to Help Hispanic Americans Better Understand Chronic Pain and Pain Management
3. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
4. Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Associations 71st Annual Scientific Sessions
5. Neuland Labs Launches Expanded Peptide Manufacturing Capabilities at 22nd American Peptide Symposium
6. Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families
7. Metabolic Solutions Development Company to Present Recent Findings on the Therapeutic Potential of Increasing Brown Fat in the Treatment of Diabetes at Annual American Diabetes Association Conference
8. American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial Due to Particulates
9. American Medical Systems Announces Large-Scale, Physician-Led Registry of Penile Implants
10. Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies
11. Thomson Reuters - NPR Health Poll Finds Three-Quarters of Americans Support Government Insurance Subsidies for Birth Control Pills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Maharashtra, February 12, 2016 ... research report titled Chronic Inflammation Global Clinical Trials ... snapshot of the global clinical trials landscape along ... trials by Region, Country (G7 & E7), Trial ... status and reviews top companies involved and enlists ...
(Date:2/11/2016)... Feb. 11, 2016 Stem cells are primitive ... by self-renewal and the capacity to differentiate into mature ... discovery, as the first mouse embryonic stem cells were ... until 1995 that the first culturing of embryonic stem ... were not produced until 2006 As a result of ...
(Date:2/11/2016)... 11, 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ... the lives of pets, today announced the submission to ... Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  ... of Zimeta for the control of pyrexia (fever) in ... --> --> The Chemistry, Manufacturing, ...
Breaking Medicine Technology:
(Date:2/12/2016)... Pa. (PRWEB) , ... February 12, 2016 , ... Every ... heaters. , This winter the West Penn Burn Center, part of the ... Company #1, to bring you the “Space Heaters Need Space” campaign. ...
(Date:2/12/2016)... ... February 12, 2016 , ... The Jones Agency, a ... across eastern Texas, is launching a cooperative charity drive with the Tarrant Area Food ... more than 50,000 individuals and families in need, the Tarrant County Food Bank offers ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... the Pittsburgh metro area, celebrates the beginning of the latest charity campaign in ... social skills through art. Donations to this worthy cause are currently being accepted ...
(Date:2/12/2016)... , ... February 12, 2016 , ... For Coast Dental ... Suzan Sweeney, RDH, and dental assistant Terrell Moore shortly before 7 a.m. to volunteer ... of dental professionals, donating their time and skills to help hundreds of uninsured and ...
(Date:2/12/2016)... ... February 12, 2016 , ... Nearly every health website and ... These articles generally list between five and 15 foods that should be consumed ... one of these lists and believes that nutritious eye healthy foods are extremely ...
Breaking Medicine News(10 mins):